ReviewCureus2022
Chronic Kidney Disease: Its Relationship With Obesity.
Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.
- Pooled it
- Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.Advances in therapy · 2026Article
- Cardiorenal outcomes of weight loss interventions in people with CKD and type 2 diabetes.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026Article
- Prevalence of Obesity, Comorbidities, and Eligibility for Pre-Transplant Bariatric Surgery in 275 Patients Awaiting Kidney Transplant at a Single Center in Germany.Annals of transplantation · 2026Article
- Protective Effects of Chitosan and Rosuvastatin on Renal Structure and Lipid Metabolism in Rabbits Fed a High-Fat Diet.Medicina (Kaunas, Lithuania) · 2026Article
- Effect of Doum (Frontiers in nutrition · 2026Article
- Article
- Global Trends and Projections in Chronic Kidney Disease Burden from Diabetes, Hypertension, and Glomerulonephritis: A Population-Based Study.Kidney & blood pressure research · 2026Article
- Palmitic Acid-induced Renal Injury: Unravelling the Molecular Mechanisms and the Protective Role of Lycopene.Cell biochemistry and biophysics · 2025Article
- Cognitive Impairment: A Novel Risk Factor for Rapid Kidney Function Decline and Incident CKD in Middle-Aged Adults.Kidney360 · 2025Article
- Interplay of obesity and parasitic infection: current evidence of immunogenesis, tumorigenesis and leptin receptor involvement.Nutrition & metabolism · 2025Review
- High-Fat-Diet-Induced Kidney Injury in Rats: The Role of Tart Cherry Supplementation.Antioxidants (Basel, Switzerland) · 2025Article
- Metabolic Dysfunction-Associated Steatotic Liver Disease as a Risk Factor for Chronic Kidney Disease: A Narrative Review.Biomedicines · 2025Review
- A High-Fat Diet Increases Kidney Fibrosis Through Regulating TGF-β and PDGF-β Signaling Pathways in Normotensive and Hypertensive Rat Models.International journal of molecular sciences · 2025Article
- Deep Phenotyping of Obesity: Electronic Health Record-Based Temporal Modeling Study.Journal of medical Internet research · 2025Article
- Development and validation of a BMI stratified mortality prediction model for patients with COPD complicated by HF using the MIMIC-IV database.Scientific reports · 2025Article
- The Hidden Price of Plenty: Oxidative Stress and Calorie-Induced Cardiometabolic Dysfunction.Life (Basel, Switzerland) · 2025Review
- Combined sedentarism and high-fat diet induce early signs of kidney injury in C57BL/6J mice.American journal of physiology. Renal physiology · 2025Article
- The Therapeutic Potential of Theobromine in Obesity: A Comprehensive Review.Nutrition reviews · 2025Review
- Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A significant obstacle to avoiding chronic illnesses in people worldwide is the increasing development of obesity. They are supported by economic expansion, mechanized transportation, a rise in sedentary behavior, and a switch from a wholesome, healthy diet to processed foods and high-calorie meals, including fast food and sugary drinks. Many developed or emerging countries have seen the prevalence of obesity in their populations increase twice over. Therefore, it must now be treated as a disease of concern. Since obesity is intimately linked to diabetes and hypertension and is linked to hemodynamic, structural, and histological renal alterations, it has been identified as one of the major causes of chronic kidney disease (CKD). Type 2 diabetes mellitus (Type-2 DM) and hypertension are directly related to obesity. A lack of insulin sensitivity intensifies the effects of angiotensin-II, aggravates proteinuria, and triggers the production of inflammatory cytokines, which contribute to the pathophysiological mechanism underlying renal damage. These conditions include glomerular hyperfiltration, hypertrophy, hypercellularity, and widening of mesangial regions. These days, obesity is a serious issue that needs to be addressed. If a child is obese from birth, then the negative consequences of obesity on the kidneys also occur in childhood. Although it is simple to prevent, it is recommended that children be encouraged to play outside, eat a decent, nutritious, and balanced diet, and consume as little fast food as possible. Obesity is a problem that affects people from their earliest years of life. We need to increase public awareness so that people in their middle years consider health and well-being a priority. They must be aware of the subsequent issues that even mild obesity might cause, such as CKD, chronic cardiac illnesses, hypertension, diabetes, etc. We looked up the following terms in PubMed, Medline, and Google: "obesity," "CKD," "Diabetes," "Hypertension," "Developmental Programming/developmental origins of health and disease (DOHaD)," and "Renal programming" to describe the relationship between CKD and obesity as a risk factor in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.